90 related articles for article (PubMed ID: 1981892)
1. [Drug therapy of intractable Pseudomonas infections].
Tanimoto S
Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1669-73. PubMed ID: 1981892
[No Abstract] [Full Text] [Related]
2. [Chemical structure, anti-bacterial activity and pharmacokinetics of aminoglycosides].
Matsumoto T; Kumazawa J
Nihon Rinsho; 1991 Oct; 49(10):2284-90. PubMed ID: 1749084
[No Abstract] [Full Text] [Related]
3. [Pseudomonas aeruginosa pneumonia].
Watanabe K
Nihon Rinsho; 1991 Oct; 49(10):2306-11. PubMed ID: 1749086
[No Abstract] [Full Text] [Related]
4. [Application of macrolides to diffuse panbronchiolitis].
Kudoh S
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():554-8. PubMed ID: 17455680
[No Abstract] [Full Text] [Related]
5. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
Reinert P
Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
[TBL] [Abstract][Full Text] [Related]
6. [Trend of therapy in Pseudomonas aeruginosa infections].
Jannuzzi C; Tassara A
G Mal Infett Parassit; 1971 Nov; 23(11):1051-4. PubMed ID: 5004852
[No Abstract] [Full Text] [Related]
7. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.
Elkhouly AE; el-Sokkary MA; el-Emam MA
Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331
[No Abstract] [Full Text] [Related]
8. [Urinary tract infections caused by Pseudomonas aeruginosa].
Ohi Y; Goto T; Mizuma Y
Nihon Rinsho; 1991 Oct; 49(10):2323-30. PubMed ID: 1660946
[No Abstract] [Full Text] [Related]
9. [Intractable bacterial infection--review].
Matsumoto K; Nagatake T; Oishi K; Kamrudin A
Nihon Rinsho; 1994 Feb; 52(2):291-6. PubMed ID: 8126875
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative infections due to Pseudomonas aeruginosa].
Ishikawa S; Yura J
Nihon Rinsho; 1991 Oct; 49(10):2336-41. PubMed ID: 1721097
[No Abstract] [Full Text] [Related]
11. [Role of antibiotics in infections due to Pseudomonas aeruginosa].
Výmola F; Jedlicková Z
Cesk Epidemiol Mikrobiol Imunol; 1972 Jul; 21(4):176-81. PubMed ID: 4262242
[No Abstract] [Full Text] [Related]
12. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
Zavascki AP
Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266
[No Abstract] [Full Text] [Related]
13. Questioning the paradigm: monotherapy vs combination antimicrobial therapy for treatment of Pseudomonas aeruginosa.
DeRyke CA; Kuti JL; Nicolau DP
Conn Med; 2005 May; 69(5):271-5. PubMed ID: 16114642
[No Abstract] [Full Text] [Related]
14. [Sensitivity in vitro to antibiotics and chemotherapeutic agents in various hospital strains of Pseudomonas aeruginosa].
Bertaggia A; De Negri M
Boll Ist Sieroter Milan; 1974; 50(1):45-53. PubMed ID: 4204863
[No Abstract] [Full Text] [Related]
15. [Pattern of antibiotic resistance of Pseudomonas aeruginosa isolated from clinical specimens 1981-1985].
Patzer J; Dzierzanowska D
Med Dosw Mikrobiol; 1987; 39(4):236-44. PubMed ID: 3125397
[No Abstract] [Full Text] [Related]
16. [Therapies for intractable respiratory infection due to Pseudomonas aeruginosa].
Nasu M
Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():51-5. PubMed ID: 15796056
[No Abstract] [Full Text] [Related]
17. [Chemotherapy of infections caused by Pseudomonas aeruginosa (pyocyanosis)].
Chernomordik AB; Panchenko MK; Bulycheva NP
Klin Med (Mosk); 1982 Jun; 60(6):17-20. PubMed ID: 6811797
[No Abstract] [Full Text] [Related]
18. Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections.
Burgess DS
Clin Infect Dis; 2005 Feb; 40 Suppl 2():S99-104. PubMed ID: 15712103
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine.
Trott DJ; Moss SM; See AM; Rees R
Aust Vet J; 2007 Nov; 85(11):464-6. PubMed ID: 17970852
[No Abstract] [Full Text] [Related]
20. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
